Welcome to Medications.com

Forest Laboratories, Inc. Reports Q3'08 Diluted Earnings Per Share ... - Earthtimes

Namenda sales exceeded $200 million for the first time, while Lexapro also generated record sales and income from the Benicar(R) co-promotion remained ...

http://www.earthtimes.org/article... | Posted: Tue Jan 15 07:52:26 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea